Eugit Therapeutics YC 申请
Eugit Therapeutics 在 Summer 2022 批次的 Y Combinator 中作为一家 Healthcare 公司进行过。以下是：公司做什么、谁创立了它，以及其 YC 申请，按照真实 YC 表格逐题重建。
- YC 批次
- Summer 2022
- 行业
- HealthcareTherapeutics
- 团队规模
- 2
- 状态
- Active
- 已发布
- 2022
创始人
Nizar BatadaFounder
Eugit Therapeutics 做什么
Eugit Therapeutics targets the issue of non-specific drugs that cause toxicity and clinical trial failures, affecting millions with tissue-specific inflammatory diseases. TAGHOME delivers drugs with precision to diseased tissues using T cell receptors, enhancing safety and improving efficacy. Our initial focus is on the 3.1 million U.S. individuals with Inflammatory Bowel Disease, aiming to initiate clinical trials within two years. Cofounded by George Church (Harvard) and funded by Y Combinator (S22).
Eugit Therapeutics 的 YC 申请，重建版
Y Combinator 申请
Eugit Therapeutics，Summer 2022 期。来自公开数据的真实申请问题解答。
- Founders2
- Company7
- Progress7
- Idea4
- Equity3
- Curious2
- Batch Preference1
Company
Eugit Therapeutics
Enabling Tissue Targeting of Therapies
We are building TAGHOME, a platform that uses T cell receptors to deliver drugs precisely to diseased tissues. This targets tissue-specific inflammatory diseases, aiming to improve safety and efficacy by reducing off-target toxicity. Our initial focus is on Inflammatory Bowel Disease patients in the U.S.
We live and work in San Francisco and South San Francisco, CA, and will be based there after YC.
San Francisco is a biotech and synthetic biology hub with access to expertise and partners necessary for our therapeutic development. Being local makes clinical partnerships and team collaboration easier.
21 更多回答 在完整申请中
Founders, Progress, Idea, Equity, Curious, Batch Preference 包含在完整版中。创建免费账户即可在 YC Insights 中打开，紧邻每个其他 YC 批次。
常见问题解答
这是 Eugit Therapeutics 的真实 YC 申请吗？
不是。Y Combinator 对提交的申请保密。这是重建版：使用 Eugit Therapeutics 的公开数据（发布笔记、创始人背景、产品描述）回答真实的 YC 表格问题。它展示了像 Eugit Therapeutics 这样的公司会如何向 YC 自我介绍，而不是他们提交的文本。
Eugit Therapeutics 是哪个 YC 批次的？
Eugit Therapeutics 是 Y Combinator Summer 2022 批次的成员。
谁创立了 Eugit Therapeutics？
Eugit Therapeutics 由 Nizar Batada 创立。
Eugit Therapeutics 做什么？
Enabling Tissue Targeting of Therapies
如何阅读完整的重建申请？
创建免费的 Round Funded 账户。YC Insights 中包含 Eugit Therapeutics 的完整 26 个问题的版本，以及其他所有 YC 批次的公司信息。
更多 YC 初创公司，例如 Eugit Therapeutics
